Federal contract award
75F40123P00111
FDA SEEKS TO IMPROVE THE COMPLETENESS AND ACCURACY OF OUR INVENTORY OF PHARMACIES WHICH MAY BE SUBJECT TO REGULATION. WE SEEK TO OBTAIN DATA ABOUT PHARMACY ESTABLISHMENTS THAT INCLUDES, BUT IS NOT LIMITED TO, PHARMACY FACILITY PHYSICAL LOCATION, STAT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 519290 — Web Search Portals and All Other Information Services |
| PSC | DC10 — Data center services delivered as a service contract. Offsite data center facilities using the resources provided by 3rd parties. May be part of an Infrastructure as a Service offering. |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $64.3K |
| Current contract value | $64.3K |
| Potential contract value / ceiling | $80.6K |
| Start date | May 16, 2023 |
| Current end date | Jul 31, 2027 |
| Potential end date | Jul 31, 2028 |
| Latest award activity | Jul 27, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 5 of 5 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 27, 2026 | P00004 | $16.3K | FDA SEEKS TO IMPROVE THE COMPLETENESS AND ACCURACY OF OUR INVENTORY OF PHARMACIES WHICH MAY BE SUBJECT TO REGULATION. WE SEEK TO OBTAIN DATA ABOUT PHARMACY ESTABLISHMENTS THAT INCLUDES, BUT IS NOT LIMITED TO, PHARMACY FACILITY PHYSICAL LOCATION, STAT |
| Jul 31, 2025 | P00003 | $16.3K | FDA SEEKS TO IMPROVE THE COMPLETENESS AND ACCURACY OF OUR INVENTORY OF PHARMACIES WHICH MAY BE SUBJECT TO REGULATION. WE SEEK TO OBTAIN DATA ABOUT PHARMACY ESTABLISHMENTS THAT INCLUDES, BUT IS NOT LIMITED TO, PHARMACY FACILITY PHYSICAL LOCATION, STAT |
| Mar 21, 2025 | P00002 | $0 | FDA SEEKS TO IMPROVE THE COMPLETENESS AND ACCURACY OF OUR INVENTORY OF PHARMACIES WHICH MAY BE SUBJECT TO REGULATION. WE SEEK TO OBTAIN DATA ABOUT PHARMACY ESTABLISHMENTS THAT INCLUDES, BUT IS NOT LIMITED TO, PHARMACY FACILITY PHYSICAL LOCATION, STAT |
| Apr 23, 2024 | P00001 | $15.9K | FDA SEEKS TO IMPROVE THE COMPLETENESS AND ACCURACY OF OUR INVENTORY OF PHARMACIES WHICH MAY BE SUBJECT TO REGULATION. WE SEEK TO OBTAIN DATA ABOUT PHARMACY ESTABLISHMENTS THAT INCLUDES, BUT IS NOT LIMITED TO, PHARMACY FACILITY PHYSICAL LOCATION, STAT |
| May 16, 2023 | 0 | $15.9K | FDA SEEKS TO IMPROVE THE COMPLETENESS AND ACCURACY OF OUR INVENTORY OF PHARMACIES WHICH MAY BE SUBJECT TO REGULATION. WE SEEK TO OBTAIN DATA ABOUT PHARMACY ESTABLISHMENTS THAT INCLUDES, BUT IS NOT LIMITED TO, PHARMACY FACILITY PHYSICAL LOCATION, STAT |
Estimated positioning window
Jul 31, 2027 – Jan 31, 2028
45/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 45/100. Available recorded signals: 40 points.
- Contract end 2028-07-31 (645 days from calculation)
- +25 points
- 1 historical awards in this buyer and category group
- +0 points
- 5 recorded award transactions
- +10 points
- Latest award action: 2026-07-27
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.